Skip to main content
Premium Trial:

Request an Annual Quote

Journal Editor Resigns

David Curtis says he resigned as editor-in-chief of the Annals of Human Genetics after it – and other journals – declined to publish an article he and his colleagues wrote that urged academic journals to take a stance on human rights violations in China, the Guardian reports.

Curtis, a University College London professor, tells the Guardian that he found the allegations of abuses in Xinjiang, China, against Uyghurs untenable, especially reports of mass DNA collection. He adds that those allegations should be particularly troubling for the field of genetics. "I resigned because publication of the article was blocked by senior managers at Wiley who should have no say in the content of a scientific journal," Curtis tells the Guardian.

As the Guardian reports, Curtis also began rejecting article submissions from researchers in China, which Wiley says violated its policy against discrimination on national origin.

Other publishers to which the article was submitted tell the Guardian that a boycott would be counterproductive. "Our decision was not in deference to China and we do not believe that a blanket ban on publishing science from China or any other country would be helpful," a BMJ spokesperson tells it.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.